Von Willebrand Disease
📧 Sign up to get email alerts when something new happens for Von Willebrand Disease.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-07-15EMA Authorised: Veyvondi (vonicog alfa) — Baxalta Innovations GmbH
EMA authorised Veyvondi (vonicog alfa) by Baxalta Innovations GmbH for von Willebrand diseases.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: The Severe Von Willebrand Disease (sVWD) Patient Registry
The document reports on a clinical trial registry for severevon Willebrand disease (sVWD). It indicates the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: ATHNdataset Registry
The ATHNdataset Registry is currently recruiting participants; sponsored by the American Thrombosis and Hemostasis Network, the registry cov…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Study of Bleeding and Treatment in Participants With Von Willebrand Disease
This clinical trial update describes a study on bleeding and treatment in people with Von Willebrand disease that is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD) [Phase 3]
A Phase 3 clinical trial evaluating subcutaneous VGA039 in patients with Von Willebrand disease is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Development of a Device for Evaluating Primary Hemostasis Under Whole Blood Flow Conditions
Clinical trial update describing the development of a device to evaluate primary hemostasis under whole blood flow conditions; the study is …
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: A Study on the Outcomes of Recombinant Von Willebrand Factor on Demand Treatment and Prevention and Treatment of Bleeding During and After Surgery in Adults With Inherited Von Willebrand Disease in the United Kingdom (UK)
This completed UK clinical trial evaluated recombinant von Willebrand factor used on demand and for prevention and treatment of bleeding dur…
-
FDA approval · 2026-02-27FDA Approved: DESMOPRESSIN ACETATE — Original Application (Caplin Steriles Limited)
FDA approved Desmopressin Acetate from Caplin Steriles Limited under an Original Application (ANDA). This marks the approval of a generic De…
-
FDA approval · 2026-02-25FDA Approved: DESMODA — Original Application (Eton Pharmaceuticals, Inc.)
FDA approves DESMODA (desmopressin acetate oral solution) under an original NDA from Eton Pharmaceuticals; the product provides a new oral f…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: An Observational Study of Vonicog Alfa (rVWF) in Pediatric Participants With Von Willebrand Disease (vWD)
An observational study is underway to evaluate Vonicog Alfa (recombinant von Willebrand factor) in pediatric participants with von Willebran…
-
CLINICAL_TRIALS trial_result · 2026-02-20Clinical Trial Update: Efficacy, PK, Immunogenicity and Safety of Wilate in Severe Von Willebrand Disease (VWD) Patients <6 Years of Age [Phase 3]
Phase 3 clinical trial update evaluating the efficacy, pharmacokinetics, immunogenicity, and safety of Wilate in severe Von Willebrand Disea…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Clinical Spectrum and Management of Von Willebrand Disease Among Children in Assiut Governorate
This clinical trial update outlines a pediatric study protocol on the clinical spectrum and management of Von Willebrand disease in Assiut G…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: Recombinant vWF Concentrate and ECMO [Phase 1]
A Phase 1 clinical trial evaluating a recombinant von Willebrand factor concentrate in patients undergoing ECMO for a bleeding disorder is c…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Endothelial Colony-Forming Cells in Patients With VWD, AVWS and Healthy Subjects
This clinical trial evaluates the safety and feasibility of endothelial colony-forming cells in people with von Willebrand disease, acquired…
-
EMA approval · 2026-01-20EMA Authorised: Veyvondi (vonicog alfa) — Baxalta Innovations GmbH
The European Medicines Agency authorised Veyvondi (vonicog alfa) by Baxalta Innovations GmbH for the treatment of von Willebrand disease. Th…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Clinical trial update for ATHN Transcends, a natural history study of non-neoplastic hematologic disorders, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: A Study of Recombinant Von Willebrand Factor (rVWF) in Chinese Participants With Von Willebrand Disease (vWD) [Phase 3]
Phase 3 clinical trial of recombinant von Willebrand factor (rVWF) in Chinese participants with von Willebrand disease is currently recruiti…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Von Willebrand Factor in Pregnancy (VIP) Study
A recruiting clinical trial investigating von Willebrand factor in pregnancy (VIP Study) sponsored by the University of Washington. It conce…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study
A clinical trial is recruiting to evaluate progestin-based treatment for heavy menstrual bleeding in people with bleeding disorders, includi…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: A Study Assessing HMB-002 in Participants With Von Willebrand Disease [Phase 1, Phase 2]
This clinical trial update notes a Phase 1/2 study of the investigational agent HMB-002 for Von Willebrand disease. The trial is currently r…
-
CLINICAL_TRIALS trial_result · 2025-11-28Clinical Trial Update: Frequency of Hemorrhages Associated With the Functional Anomalies of Willebrand Factor in Emergency Patients
A completed clinical trial evaluated the frequency of hemorrhages associated with functional anomalies of von Willebrand factor in emergency…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: NON CANONICAL ACTIVATION OF BOOD COAGULATION
A clinical trial update describes a study on non-canonical activation of blood coagulation, listing von Willebrand disease and carotid arter…
-
CLINICAL_TRIALS trial_result · 2025-10-31Clinical Trial Update: Prevent Postpartum Hemorrhage in Women With Von Willebrand Disease: The VWD-WOMAN Trial [Phase 3]
Phase 3 VWD-WOMAN trial evaluating prevention of postpartum hemorrhage in women with von Willebrand disease has completed and posted results…
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD) [Phase 3]
Phase 3 clinical trial evaluating Vonicog alfa (recombinant von Willebrand factor) in children with severe von Willebrand disease is current…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Impact of IV Iron on Bleeding Symptoms in Iron Deficient Patients With Inherited Bleeding Disorders
Clinical trial investigating whether intravenous iron can reduce bleeding symptoms in iron-deficient patients with inherited bleeding disord…